Clinical Trials in Orphan Drugs

CTOD2024 will bring together leading experts across Europe to discuss strategies and best practices for clinical trials in rare diseases and orphan drugs.

The Conference will welcome clinical trials community from academia, clinical research entities, pharmaceutical, biomedical.

The Conference will focus on the following key areas:

• Strategically selecting trial sites.
• Patients identification
• Shall companies multiply sites all over Europe?
• Identifying all stakeholders
• Building relationships with patient groups
• Creating European registries and expert groups and developing disease awareness
• Conducting trans-border clinical trials across Europe
• Preparing for pre-launch activities including early access programs
• Compassionate use and named patient programs in Europe
• Understanding clinical trial landscape beyond big 5 countries
• Avoiding pitfalls and optimizing orphan drug development

We hope you will join us at CTOD2024 in London to connect with peers, discuss strategies, and advance orphan drug development in Europe.

Sincerely,